The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.
December 5th 2024
The authors suggest that targeted interventions to mitigate financial toxicity should be implemented to better support patients.
Study Finds Novel Mechanism of Resistance to Immunotherapy Targeting HER2
February 26th 2021As immunotherapies continue to show promise in more effectively combating several tumor types, many current strategies focus on ensuring the efficient delivery of active cytotoxic cells directly to tumors.
Read More
Improving Outcomes for Patients With Breast Cancer
Current cancer research focuses heavily on adjunct immunotherapy in combination with traditional chemotherapy.
Read More
Weight Loss After HER2-positive Early Breast Cancer Diagnosis Associated With Worse Outcomes
February 19th 2021A 5% weight loss over 2 years in patients with HER2-positive early breast cancer was associated with worse outcomes, according to new research that investigated the BMI data of these patients.
Read More
First Mammography Screening Guidelines Issued for Older Survivors of Breast Cancer
February 2nd 2021The guidelines recommend discontinuing routine mammograms for survivors with a life expectancy under 5 years, considering stopping screening for those with a 5- to 10-year life expectancy, and continuing mammography for those whose life expectancy is greater than 10 years.
Read More
Study: Male Breast Cancer Patients Have High Prevalence of Heart Disease Risk Factors
February 1st 2021Research highlights the need for cardiologists and cardio-oncologists to be involved in the treatment of men with breast cancer due to common risk factors and potential cardiotoxic effects of treatment.
Read More
Triggering a Tumor Antiviral Immune Response in Patients With Triple-Negative Breast Cancer
January 22nd 2021During a study investigating therapeutics that target how RNA splicing activates antiviral immune pathways in triple-negative breast cancers, researchers observed that endogenous RNA in tumor cells that had been mis-spliced is able to mimic an RNA virus.
Read More
Study: Statins May Protect the Heart from Chemotherapy Treatment of Early Breast Cancer
January 7th 2021According to the study authors, previous small studies suggested that women taking statins may have less heart muscle damage from these types of chemotherapy, yet the exact mechanisms of how statins protect against the cardiac cell damage remains unknown.
Read More
Margetuximab-cmkb Approved by FDA With Chemotherapy for Metastatic HER2-Positive Breast Cancer
December 17th 2020FDA approves margetuximab-cmkb (Margenza) in combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have previously received 2 or more anti-HER2 regimens.
Read More
Socio-Economic Factors, Policy Changes Impact Disparities Among Breast Cancer Patients
December 10th 2020Session at at the San Antonio Breast Cancer Symposium featured several abstract presentations on disparities in health care access in breast cancer, including research on the necessity of avoiding a one-size-fits-all approach to medicine.
Read More